Literature DB >> 2783121

Irreversible inhibition of v-src tyrosine kinase activity by herbimycin A and its abrogation by sulfhydryl compounds.

Y Uehara1, H Fukazawa, Y Murakami, S Mizuno.   

Abstract

Herbimycin A, an antibiotic which reverses Rous sarcoma virus transformation, inhibited irreversibly the auto- and trans-phosphorylation activities of p60v-src in in vitro immune complex kinase assays. The addition of a sulfhydryl compound such as dithiothreitol, 2-mercaptoethanol, glutathione (reduced form) or cysteine abolished the ability of herbimycin A to inactivate p60v-src kinase as well as the ability to reverse transformed cell morphology, whereas the addition of oxidized glutathione, cystine or methionine showed no effect. The sulfhydryl alkylating reagent N-ethylmaleimide also, although less effectively, inactivated p60v-src kinase activity in vitro. These results suggest the likelihood that sulfhydryl groups of p60v-src are involved in the inactivation of v-src tyrosine kinase activity by herbimycin A.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2783121     DOI: 10.1016/0006-291x(89)92293-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  36 in total

Review 1.  Geldanamycin: the prototype of a class of antitumor drugs targeting the heat shock protein 90 family of molecular chaperones.

Authors:  H J Ochel; K Eichhorn; G Gademann
Journal:  Cell Stress Chaperones       Date:  2001-04       Impact factor: 3.667

2.  Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro.

Authors:  M B Toledano; W J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

3.  Src family kinases play multiple roles in differentiation of trophoblasts from human term placenta.

Authors:  Georges Daoud; Eric Rassart; André Masse; Julie Lafond
Journal:  J Physiol       Date:  2006-01-12       Impact factor: 5.182

4.  Beta 2-integrin LFA-1 signaling through phospholipase C-gamma 1 activation.

Authors:  S B Kanner; L S Grosmaire; J A Ledbetter; N K Damle
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

5.  The signal transduction mechanism responsible for gamma interferon-induced indoleamine 2,3-dioxygenase gene expression.

Authors:  Y Koide; A Yoshida
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

6.  Inhibition of tyrosine phosphorylation prevents T-cell receptor-mediated signal transduction.

Authors:  C H June; M C Fletcher; J A Ledbetter; G L Schieven; J N Siegel; A F Phillips; L E Samelson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

7.  Conversion of epidermal growth factor (EGF) into a stimulatory ligand for A431-cell growth by herbimycin A by decreasing the level of expression of EGF receptor.

Authors:  Y Murakami; H Fukazawa; S Mizuno; Y Uehara
Journal:  Biochem J       Date:  1994-07-01       Impact factor: 3.857

8.  Accelerated degradation of 160 kDa epidermal growth factor (EGF) receptor precursor by the tyrosine kinase inhibitor herbimycin A in the endoplasmic reticulum of A431 human epidermoid carcinoma cells.

Authors:  Y Murakami; S Mizuno; Y Uehara
Journal:  Biochem J       Date:  1994-07-01       Impact factor: 3.857

9.  Ligation of the CD5 or CD28 molecules on resting human T cells induces expression of the early activation antigen CD69 by a calcium- and tyrosine kinase-dependent mechanism.

Authors:  P Vandenberghe; J Verwilghen; F Van Vaeck; J L Ceuppens
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

10.  Effects of protein tyrosine kinase inhibitors on cytokine-induced adhesion molecule expression by human umbilical vein endothelial cells.

Authors:  M J May; C P Wheeler-Jones; J D Pearson
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.